Patients with ABI require prolonged mechanical ventilation and have a substantially higher risk for VAP due to impaired airway protection and injury-related immune dysfunction. However, routine use of ...

Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more ...

Coronary artery disease characterized by vascular calcification poses significant challenges in the field of interventional ...